IRLAB THERAPEUTICS
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the brain. IRLAB is engaged in programmes targeting core dysfunctions in Parkinson’s disease and dementias. IRLAB has identified, and is currently engaged in clinical development of, two novel compounds aimed at offering improved clinical benefit for patients with Parkinson’s disease.
IRLAB THERAPEUTICS
Industry:
Health Care Therapeutics
Founded:
2013-01-01
Address:
Göteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.irlab.se
Total Employee:
11+
Status:
Active
Contact:
+46 31 757 3800
Email Addresses:
[email protected]
Total Funding:
15.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Sitelinks Search Box
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - IRLAB Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - IRLAB Therapeutics
Official Site Inspections
http://www.irlab.se Semrush global rank: 4.93 M Semrush visits lastest month: 1.74 K
- Host name: 193.14.90.36
- IP address: 193.14.90.36
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "IRLAB Therapeutics"
Homepage - IRLAB
5 days ago Gothenburg, Sweden, November 27, 2023 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s …See details»
Management - IRLAB
He continued in this role in the new organization in NeuroSearch Sweden until 2011 when he was appointed Director of Computational Chemistry & Biology, IT. Peder is a co-founder of IRLAB …See details»
About IRLAB - IRLAB
IRLAB’s share (IRLAB A) has been traded on Nasdaq Stockholm Main Market since September 2020, a move from Nasdaq First North Premier Growth Market where the company was listed …See details»
IRLAB Therapeutics - Crunchbase Company Profile
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the brain. IRLAB is engaged in programmes targeting core dysfunctions in Parkinson’s disease and dementias. IRLAB has …See details»
IRLAB Therapeutics AB | LinkedIn
IRLAB Therapeutics AB | 1 274 följare på LinkedIn. A clinical-stage biopharma discovering and developing novel treatments for the most troublesome symptoms of Parkinson's. | IRLAB …See details»
IRLAB publishes interim report for the period January-September …
Oct 25, 2023 GOTHENBURG, SE / ACCESSWIRE / October 25, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 25, 2023 - IRLAB Therapeutics AB …See details»
Ipsen and IRLAB enter exclusive worldwide licensing agreement
Jul 15, 2021 PARIS, FRANCE and GOTHENBURG, SWEDEN, 15 July 2021 – Ipsen (Euronext: IPN; ADR: IPSEY) and IRLAB (Nasdaq Stockholm; IRLAB A) today announced the signing of …See details»
Board of directors - IRLAB
Board of directors On May 22, 2024, 7 board members were elected at the Annual General Meeting. The board has appointed an audit committee and a remuneration committee. A summary of the board members is found in the …See details»
IRLAB obtains regulatory approval to conduct Phase IIb study
Dec 21, 2021 IRLAB is a Swedish research and development company that focuses on discovery and development of novel treatments in Parkinson’s disease. The company's most …See details»
Irlab - Overview, News & Similar companies | ZoomInfo.com
May 21, 2024 Who is Irlab. IRLAB is a Swedish research and development company that focuses on developing novel treatments in Parkinson's disease. The company's most …See details»
IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study …
Dec 22, 2021 E-mail: [email protected]. Viktor Siewertz, CFO Phone: +46 727 10 70 70 E-mail: [email protected]. ... IRLAB is collaborating with a Clinical Research …See details»
Integrative Research Laboratories Sweden AB - Largestcompanies
Www.irlab.se CFAR: 53169058 Established: 2013 Subsidiary company to: Irlab Therapeutics AB (SE) Listing: Not listed Industry 1: B72 Scientific research and development - 72190 Other …See details»
IRLAB has received approval from the Swedish Medical Products …
May 6, 2024 MJFF is the world's largest non-profit funder of Parkinson's disease research and the organization's support of IRL757 provides a strong external validation of the project's …See details»
IRLAB publishes the Annual Report for 2021
Apr 8, 2022 Viktor Siewertz, CFO Phone: +46 727 10 70 70 E-mail: [email protected] This information is information that IRLAB Therapeutics is obliged to make public pursuant to the …See details»
IRLAB has Received Approval from the Swedish Medical ... - BioSpace
May 6, 2024 MJFF is the world's largest non-profit funder of Parkinson's disease research and the organization's support of IRL757 provides a strong external validation of the project's …See details»
IRLAB to Present at BioStock Life Science Summit 2024 (MFN)
Nov 13, 2024 Gothenburg, Sweden, November 13, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's …See details»
IRLAB: Invitation to the interim report for Q2 2023 ... - Placera
Aug 23, 2023 E-mail: [email protected]. Viktor Siewertz, CFO Phone: +46 727 10 70 70 E-mail: [email protected]. About IRLAB. IRLAB is discovering and developing a …See details»
IRLAB Therapeutics Company Profile - Office Locations ... - Craft
Sep 6, 2024 IRLAB Therapeutics has 5 employees at their 1 location and kr5.68 m in annual revenue in FY 2023. See insights on IRLAB Therapeutics including office locations, …See details»
Investors - IRLAB
Gothenburg, Sweden, November 29, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today …See details»
Financial reports - IRLAB
Oct 30, 2024 irlab therapeutics ab arvid wallgrens backe 20 413 46 gÖteborg, sverige [email protected] +46(0)31 757 38 00See details»